Regulation - Asia-Pacific, Generics

Filter

Current filters:

Asia-PacificGenerics

Popular Filters

1 to 25 of 39 results

Indian drugmakers readying for next “Patent cliff”

24-02-2014

The strategic drug reviews, as well as mergers and acquisitions – such as Actavis buying out Forest…

Asia-PacificGenericsIndiaMergers & AcquisitionsPatentsPharmaceuticalRegulation

Another ban by US FDA on a Ranbaxy production facility

Another ban by US FDA on a Ranbaxy production facility

24-01-2014

As if the Indian drug major has not had enough negative news from the US regulator, the US Food and Drug…

Asia-PacificDaiichi SankyoGenericsIndiaNorth AmericaProductionRanbaxy LaboratoriesRegulationUSA

Celltrion’s trastuzumab biosimilar, Herzuma, approved in South Korea

16-01-2014

South Korean biopharmaceutical firm Celltrion has received approval for its cancer treatment biosimilar…

Asia-PacificBiosimilarsCellTrionGenericsHerceptinHerzumaOncologyRegulationRoche

Russia, Ukraine and the Baltic states increasing in importance on the contract manufacturing market

Russia, Ukraine and the Baltic states increasing in importance on the contract manufacturing market

11-12-2013

Russia seems to be an attractive country for pharmaceutical contract manufacturing, chiefly because of…

Asia-PacificChinaEastern EuropeGenericsIndiaProductionRegulationRussiaUkraine

Mylan-Biocon Herceptin biosimilar gets first Indian approval

Mylan-Biocon Herceptin biosimilar gets first Indian approval

26-11-2013

US generic major Mylan says that its partner, India-based biotechnology firm Biocon has received approval…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazMylan LaboratoriesOncologyRegulationRoche

Dramatic increase in use of generic drugs in Japan confirmed

Dramatic increase in use of generic drugs in Japan confirmed

15-10-2013

A subcommittee of Japan’s Central Social Insurance Medical Council looked at the effect of the April…

Asia-PacificGenericsMarkets & MarketingRegulation

Australian generics group releases new edition of Code of Practice for public consultation

Australian generics group releases new edition of Code of Practice for public consultation

26-09-2013

Australia’s Generic Medicines Industry Association this morning released the draft third edition of…

Asia-PacificGenericsMarkets & MarketingRegulation

Rising focus on R&D in India whose pharma exports have reached $14.5 billion

Rising focus on R&D in India whose pharma exports have reached $14.5 billion

24-09-2013

The domestic pharmaceutical industry in India has been growing at a CAGR of over 14.5% for the past four…

Asia-PacificGenericsMarkets & MarketingRegulation

Ban on FDA-regulated drugs from Ranbaxy's Mohali plant

17-09-2013

There was another blow for India's largest drugmaker Ranbaxy Laboratories (BSE: 500359) yesterday (September…

Asia-PacificDaiichi SankyoGenericsNorth AmericaProductionRanbaxy LaboratoriesRegulation

Generics market in Southeast Asia set for growth

15-09-2013

With its fast-growing, young population and uninsured majority in Southeast Asia, countries in the region…

Asia-PacificGenericsMarkets & MarketingPricingRegulation

Mylan's deal to acquire Strides Arcolab's unit looks set to proceed

22-08-2013

US generics and specialty drugmaker Mylan (NYSE: MYL) $1.6-billion foreign direct investment proposal…

Agila SpecialitesAsia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesRegulationStrides Arcolab

Japan's MHLW approves 367 generics, but what does this mean?

21-08-2013

Japan's Ministry of Health Labor and Welfare (MHLW) approved 367 items of generic drugs last week. Launch…

Asia-PacificDiovanGenericsNovartisPharmaceuticalPricingRegulation

New Zealand approves proposals diazepam, gabapentin and naltrexone listing

12-07-2013

New Zealand's Pharmaceutical Management Agency PHARMAC has announced the approval of proposals relating…

Asia-PacificdiazepamgabapentinGenericsnaltrexoneNeurologicalPharmaceuticalRegulation

Wockhardt's "poor cleaning practices and forged documents" lead to recall of 16 drugs in the UK

11-07-2013

Pharmacies, clinics and wholesalers in the UK have been asked to return 16 different medications made…

Asia-PacificGenericsRegulationWockhardt

Indian pharma threatened by trend of shifting R&D operations overseas: survey

04-07-2013

Red tape is putting India's multi-billion dollar worth pharmaceutical industry at risk, with most of…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalRegulationResearch

China forms global alliance with Germany's blue inspection for drug quality

11-06-2013

Effective June 1, 2013, the China Chamber of Commerce for Import & Export of Medicines & Health Products…

Asia-PacificEuropeGenericsPharmaceuticalProductionRegulation

US DoJ says Ranbaxy pleads guilty and agrees to pay $500 million in settlements

14-05-2013

In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA, a subsidiary…

Asia-PacificDaiichi SankyoFinancialGenericsLegalNorth AmericaProductionRanbaxy LaboratoriesRegulation

New Zealand decision to fund unapproved medicines for various conditions

07-03-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, has announced the approval of an agreement with…

Asia-PacificFinancialGenericsRegulation

India's Elder Pharma to enter EU markets; comment on GSK Indian OTC moves

26-11-2012

Indian drugmaker Elder Pharmaceuticals says it is ready to enter the European Union market following…

Asia-PacificdiosminElder PharmaceuticalsEuropeGenericsGlaxoSmithKlineMarkets & MarketingMergers & AcquisitionsPharmaceuticalRegulation

"India Pharma Inc" gearing up for the next level of growth

05-11-2012

Indian pharmaceutical companies will have to rethink business strategy in the light of several interventions…

Asia-PacificGenericsHealthcareMarkets & MarketingPharmaceuticalPricingProductionRegulation

1 to 25 of 39 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top